Promising Preliminary Results in Optic Nerve Recovery Study of NurExone’s first product ExoPTEN for Glaucoma (TSXV: NRX, OTCQB: NRXBF)
Upvotes: 2
Favorite this post:
Mark as read:
Your rating:
Add this post to a custom list
StoryNote Upvotes: 2